Table 1. Baseline characteristics of the included patients.
Characteristic | Total (N = 83) | ILMA* (n = 26) | ILMA+ non-silver dressing (n = 26) | ILMA+ silver dressing (n = 31) |
Age (mean ± SD†) years | 28.81 (14.45) | 32.88 (12.92) | 30.31 (15.41) | 24.13 (13.97) |
Duration of lesions (mean ± SD) weeks | 7.95 (2.67) | 8.31 (2.86) | 8.46 (2.15) | 7.23 (2.82) |
Number of lesions (mean ± SD) | 1.90 (1.21) | 1.77 (1.34) | 2.00 (1.47) | 1.94 (1.12) |
Male (%) | 39 (47.0) | 8 (30.8) | 11 (42.3) | 20 (64.5) |
ILMA = intralesioinal meglumine antimoniate. †Standard deviation.